4.7 Article

Lipoxin-mediated inhibition of IL-12 production by DCs: a mechanism for regulation of microbial immunity

期刊

NATURE IMMUNOLOGY
卷 3, 期 1, 页码 76-82

出版社

NATURE PUBLISHING GROUP
DOI: 10.1038/ni745

关键词

-

资金

  1. NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [Z01AI000579, ZIAAI000579] Funding Source: NIH RePORTER
  2. NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [P01DE013499] Funding Source: NIH RePORTER
  3. NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM038765, R01GM038765, R29GM038765] Funding Source: NIH RePORTER
  4. NIDCR NIH HHS [P01-DE13499] Funding Source: Medline
  5. NIGMS NIH HHS [GM-38765] Funding Source: Medline

向作者/读者索取更多资源

Lipoxins are eicosanoid mediators that show potent inhibitory effects on the acute inflammatory process. We show here that the induction of lipoxin A(4) (LXA(4)) accompanied the In vivo suppression of interleukin 12 (IL-12) responsiveness of murine splenic dendritic cells (DCs) after microbial stimulation with an extract of Toxoplasma gondii. This paralysis of DC function could not be triggered in mice that were deficient in a key lipoxygenase involved in LXA4 biosynthesis. In addition, DCs pre-treated with LXA4 became refractory to microbial stimulation for IL-12 production In vitro and mice injected with a stable LXA(4) analog showed reduced splenic DC mobilization and IL-12 responses in vivo. Together, these findings indicate that the induction of lipoxins in response to microbial stimulation can provide a potent mechanism for regulating DC function during the innate response to pathogens.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据